A Study of Two Dosage Forms of LY2886721 in Healthy Participants
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate two different formulations of LY2886721. In
addition, this study will determine how much of study drug (LY2886721) gets into the blood
steam and how long the body takes to get rid of it after taking each formulation with or
without a meal. Information about any side effects that may occur will also be collected.
Each participant may be involved in the study for approximately 7 weeks.
This study requires 4 periods. In each period, participants will receive LY2886721 as a
tablet or capsule, with or without food and water. There is a 7 day washout between each
period.